Virtus Fund Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $580K | Buy |
12,509
+7,502
| +150% | +$348K | 0.01% | 319 |
|
|
2017
Q3 | $267K | Sell |
5,007
-311
| -6% | -$16.6K | ﹤0.01% | 355 |
|
|
2017
Q2 | $340K | Sell |
5,318
-158
| -3% | -$10.1K | ﹤0.01% | 358 |
|
|
2017
Q1 | $371K | Sell |
5,476
-353
| -6% | -$23.9K | ﹤0.01% | 358 |
|
|
2016
Q4 | $410K | Hold |
5,829
| – | – | ﹤0.01% | 358 |
|
|
2016
Q3 | $414K | Hold |
5,829
| – | – | ﹤0.01% | 361 |
|
|
2016
Q2 | $301K | Hold |
5,829
| – | – | ﹤0.01% | 378 |
|
|
2016
Q1 | $369K | Sell |
5,829
-1,282
| -18% | -$81.2K | ﹤0.01% | 370 |
|
|
2015
Q4 | $798K | Buy |
7,111
+1,810
| +34% | +$203K | 0.01% | 304 |
|
|
2015
Q3 | $511K | Buy |
+5,301
| New | +$511K | ﹤0.01% | 343 |
|
|
2014
Q3 | – | Sell |
-567
| Closed | -$25K | – | 1753 |
|
|
2014
Q2 | $25K | Buy |
+567
| New | +$25K | ﹤0.01% | 2305 |
|